3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
70
Neoplasms
13
Neoplasm Metastasis
7
Brain Neoplasms
7
Head and Neck Neoplasms
6
Breast Neoplasms, Male
6
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Salivary Gland Neoplasms
2
Recurrence
2
Pancreatic Neoplasms
2
Osteitis Deformans
2
Neuroma, Acoustic
2
Neurofibromatosis 2
2
Inflammatory Breast Neoplasms
2
Glioblastoma
2
Gallbladder Neoplasms
2
Esophageal Neoplasms
2
Ependymoma
2
Colorectal Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma, Hepatocellular
2
Bile Duct Neoplasms
2
Interventions
Gemcitabine
14
Cisplatin
13
Capecitabine
11
Paclitaxel
9
Oxaliplatin
9
Fluorouracil
9
130-nm albumin-bound paclitaxel
9
pembrolizumab
7
Albumin-Bound Paclitaxel
7
Ramucirumab
6
Leucovorin
6
Carboplatin
6
Bevacizumab
6
Nivolumab
5
Irinotecan
5
Docetaxel
5
Pemetrexed
4
Everolimus
4
Erlotinib Hydrochloride
4
Cyclophosphamide
4
trastuzumab deruxtecan
3
Radiotherapy
3
Afatinib
3
zolbetuximab
2
trifluridine tipiracil drug combination
2
regorafenib
2
pralsetinib
2
cabozantinib
2
Trastuzumab
2
Ipilimumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma
×
Lapatinib
×
Clear all
No trials found.